Iodid Bc (Potassium Iodide)

Potassium iodide provides a large amount of stable iodide that is quickly taken up by the thyroid. The excess iodide saturates the sodium‑iodide symporter, preventing the gland from taking up additional iodine, including radioactive forms. This competitive inhibition limits the amount of radioactive iodine that can be incorporated into thyroid tissue.

The appropriate dose of Iodid Bc is determined by a qualified prescriber based on the specific exposure scenario, patient age, weight, and medical condition. Healthcare professionals follow national or international guidelines to select the correct amount, and patients should follow the prescribed regimen without deviation.

Safety of potassium iodide in pregnancy and lactation has not been definitively established. It may affect fetal or infant thyroid function, so use is generally reserved for situations where the benefit outweighs potential risk. Clinicians should evaluate each case individually and discuss possible concerns with the patient.

To order Iodid Bc, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Iodid Bc (potassium iodide) is the standard and most widely used iodine supplement for thyroid blocking because it delivers stable iodide rapidly and is inexpensive. Alternative agents, such as perchlorate or thiocyanate, have different mechanisms and may be less effective or have higher toxicity, making potassium iodide the preferred choice in most emergency protocols.

Iodid Bc should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat. Proper storage maintains potency and prevents degradation of the potassium iodide tablets.

Iodid Bc is administered orally, typically as a tablet that is swallowed with water. The tablet dissolves in the gastrointestinal tract, allowing rapid absorption of iodide. Administration should follow the timing recommendations provided by health authorities or the prescribing clinician, especially in relation to potential radiation exposure.

The most serious risks include severe allergic reactions such as anaphylaxis, iodide‑induced hyperthyroidism or hypothyroidism, and, in rare cases, acute thyroid storm. Patients should be monitored for signs of rash, swelling, difficulty breathing, or sudden changes in thyroid function, and seek immediate medical attention if these occur.

Individuals with a known allergy to iodine or iodide should avoid Iodid Bc. Patients with certain thyroid disorders, such as untreated hyperthyroidism, may be at increased risk of adverse effects and should only use the product under close medical supervision. Pregnant or breastfeeding women should use it only when the potential benefit justifies the possible risk.